Peptide which abrogates tnf and/or lps toxicity

Details Peptide which abrogates tnf and/or lps toxicity Peptide which abrogates tnf and/or lps toxicity

C - Chemistry, Metallurgy

07

K

C07K 7/04 (2006.01) A61K 38/04 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) C07K 14/47 (2006.01) C07K 14/525 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2112907

The present invention provides peptides which have the ability to abrogate TNF toxicity and/or LPS toxicity. The present invention further relates to compositions including these peptides as the active ingredient and methods of anti-inflammatory treatment involving the administration of this composition. The peptides of the present invention are based primarily on residue 1 to 26 of human TNF.

Affiliated with

Also associated with

Rating

Peptide which abrogates tnf and/or lps toxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide which abrogates tnf and/or lps toxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide which abrogates tnf and/or lps toxicity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1855376